Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRIW) Research & Development (2023 - 2025)

Historic Research & Development for Biofrontera (BFRIW) over the last 3 years, with Q3 2025 value amounting to $854000.0.

  • Biofrontera's Research & Development rose 2765.32% to $854000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year increase of 17716.42%. This contributed to the annual value of $2.1 million for FY2024, which is 261298.7% up from last year.
  • Per Biofrontera's latest filing, its Research & Development stood at $854000.0 for Q3 2025, which was up 2765.32% from $870000.0 recorded in Q2 2025.
  • In the past 5 years, Biofrontera's Research & Development ranged from a high of $1.2 million in Q1 2025 and a low of $11000.0 during Q2 2023
  • Moreover, its 3-year median value for Research & Development was $645000.0 (2024), whereas its average is $509800.0.
  • Examining YoY changes over the last 5 years, Biofrontera's Research & Development showed a top increase of 700000.0% in 2025 and a maximum decrease of 2765.32% in 2025.
  • Quarter analysis of 3 years shows Biofrontera's Research & Development stood at $33000.0 in 2023, then surged by 2272.73% to $783000.0 in 2024, then rose by 9.07% to $854000.0 in 2025.
  • Its Research & Development was $854000.0 in Q3 2025, compared to $870000.0 in Q2 2025 and $1.2 million in Q1 2025.